Related Experiment Video
Updated: Jul 8, 2025

06:50
Diffuse Reflectance Spectroscopy: Getting the Capillary Refill Test Under One's Thumb
Published on: December 2, 2017
9.2K
A Critical Reappraisal of the Bleeding Time
R P Channing Rodgers1,2, Jack Levin1,2
1Department of Laboratory Medicine, School of Medicine, University of California, San Francisco, California.
Seminars in Thrombosis and Hemostasis
|December 12, 2023
Summary
The bleeding time test, a historical method for assessing bleeding disorders, involves timing skin incisions. This review reevaluates its diagnostic utility and historical modifications.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- The bleeding time test, first described in 1901, is a historical method for assessing hemostasis.
- Numerous modifications, including the widely used Ivy bleeding time, have been developed to standardize the procedure.
- The test has been proposed for diagnosing platelet disorders, monitoring therapy, and predicting bleeding risks.
Approach:
- This manuscript republishes a highly cited archival review on the bleeding time test.
- The original review analyzed 862 documents discussing the bleeding time test up to 1990.
- The focus is on the historical development, modifications, and proposed applications of the bleeding time test.
Key Points:
- The bleeding time test is an invasive procedure requiring a skin incision and measurement of bleeding duration.
- Historical context traces the test from Milian's initial description to Duke's and Ivy's modifications.
- The Ivy method, involving a forearm incision and controlled venous pressure, became a frequently utilized variant.
Conclusions:
- The bleeding time test has been historically significant in evaluating hemostasis and platelet function.
- Despite its limitations, the test has been explored for diagnostic and prognostic purposes in bleeding disorders.
- This republication provides historical perspective on a foundational hemostasis assessment tool.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708

